期刊
SCIENCE
卷 358, 期 6360, 页码 218-222出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aan7969
关键词
-
资金
- American Cancer Society Postdoctoral Fellowship [PF-15-007-01-CDD]
- NSF Graduate Research Fellowships
- NSF [ECCS-1542152]
- NIH [P30 CA124435, R01CA031845, AI124743]
Bryostatin 1 is an exceedingly scarce marine-derived natural product that is in clinical development directed at HIV/AIDS eradication, cancer immunotherapy, and the treatment of Alzheimer's disease. Despite this unique portfolio of indications, its availability has been limited and variable, thus impeding research and clinical studies. Here, we report a total synthesis of bryostatin 1 that proceeds in 29 total steps (19 in the longest linear sequence, >80% average yield per step), collectively produces grams of material, and can be scaled to meet clinical needs (similar to 20 grams per year). This practical solution to the bryostatin supply problem also opens broad, facile, and efficient access to derivatives and potentially superior analogs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据